Product Type:
The Newborn Screening market is segmented into Instruments and Consumables. Instruments segment is expected to dominate the market due to the rising demand for advanced screening technologies and equipment in healthcare facilities. Consumables segment is also anticipated to witness significant growth owing to the increasing adoption of screening tests by laboratories and clinics.
Technology:
The Newborn Screening market is divided into Tandem Mass Spectrometry, Oximetry, Enzyme-Based Assays, and DNA Assays. Tandem Mass Spectrometry technology is projected to hold a substantial market share due to its high accuracy and efficiency in detecting metabolic disorders in newborns. Oximetry technology is also expected to grow significantly with the rise in the prevalence of congenital heart diseases among infants.
Test Type:
The Test Type segment includes Dried Blood Spot, Hearing Screening, and CCHD. Dried Blood Spot test is anticipated to lead the market as it is a cost-effective and non-invasive method for screening various disorders in newborns. Hearing Screening test is also likely to witness growth due to the increasing awareness about early detection of hearing impairments in infants.
End-use:
The End-use segment comprises Hospitals, Diagnostic Centers, and Research Laboratories. Hospitals are expected to be the major end-users of newborn screening services as they cater to a large number of newborns and have the required infrastructure for conducting screening tests. Diagnostic Centers and Research Laboratories are also projected to contribute significantly to the market growth with their increasing focus on early diagnosis and treatment of genetic disorders in newborns.